Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3‐kinase inhibitors, wortmannin and LY294002.

G.J. Brunn(Mayo Clinic), Josie M. Williams(Mayo Clinic), Candace J. Sabers(Mayo Clinic), Greg Wiederrecht(Mayo Clinic), John C. Lawrence(Mayo Clinic), Robert T. Abraham(Mayo Clinic)
The EMBO Journal
October 1, 1996
Cited by 723Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis